Acute leukemia

Clinics in Laboratory Medicine

Volumn 22, Issue 1, 2002, Pages 153-192

  Schumacher, Harold R ^a   Alvares, Carmelita J ^a   Blough, Ruthann I ^b   Mazzella, Fermina ^c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACTINOMYCIN; EPIPODOPHYLLOTOXIN; MELPHALAN; NITROSOUREA; PHENYLBUTAZONE; PROCARBAZINE; SULFINPYRAZONE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ASSAY; CANCER CLASSIFICATION; CHILD; CLINICAL FEATURE; CYTOCHEMISTRY; CYTOGENETICS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MOLECULAR BIOLOGY; MORPHOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0036128616     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(03)00071-4     Document Type: Review

References (77)

1. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9; 11 translocation
2. Ulex Europaeus agglutinin (UEA-1): A sensitive marker for megakaryocytes and megakaryoblasts in paraffin-embedded tissue
3. The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia
4. Is there a best transplant conditioning regimen for acute myeloid leukemia?
5. Partial deletion of long arm of chromosome 16 and bone marrow eosinophilia in acute monomyelocytic leukemia: A new association
6. Acute myelomonoblastic leukemia carrying the PEB2 beta/MYH 11 fusion gene
7. Alterations du song remarqasible par le predominance des globules blanc ou maquer hypertrophie considerable de la rate
8. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7): A report of the French-American-British Cooperative Group
9. The morphological classification of acute lymphocytic leukemia: Concordance among observers and clinical correlation
10. Proposal for recognition of minimally differentiated acute myeloid leukemia (AML-MO)
11. Proposals for the classification of the acute leukemias
12. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group
13. Cytogenetic studies in 519 consecutive de novo acute nonlymphocytic leukemia
14. Biology of disease: DNA repair and its pathogenetic implications
15. Prognostic significance of CD34 expression in childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study
16. New strategies for the treatment of acute myelogenous leukemia: Differentiation induction-present use and future possibilities
17. Graft-vs-malignancy with allogeneic blood stem cell transplantation: A potential primary treatment modality
18. Clinical relevance of CD 10 expression in childhood ALL
19. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias
20. Case of disease of the spleen in which death took place in consequence of the presence of purulent matter in the blood
21. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and leukemia group B study 8364
22. Immunodiagnosis of acute leukemia displaying ectopic antigens: Proposal for a classification of promiscuous phenotypes
23. Transient myeloproliferative disease of the newborn: Case report with placental, cytogenetic, and flow cytometric findings
24. Effects of small doses of ionizing radiation
25. Second primary malignant neoplasms in patients treated for Hodgkin's disease at St. Bartholomew's Hospital
26. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis
27. Double esterase staining of the bone marrow contributes to lineage identification in a case of minimally differentiated acute myeloid leukemia (AMLMO)
28. Treatment of relapsed and refractory acute myelogenous leukemia
29. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia
30. Acute lymphoblastic leukemia
31. Recent-onset myelodysplastic syndrome mimicking acute leukemia during infection
32. Immunophenotyping of a transient myeloproliferative disorder in a newborn with trisomy 21
33. Chromosomal abnormalities in acute leukemias
34. Acute myelogenous leukemia presenting with bulky lymphadenopathy: Case report and literature review
35. Molecular cytogenetics of leukemia
36. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia
37. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19)
38. Therapy related acute leukemia
39. Acute lymphoblastic leukemia: Survey of immunophenotypic, French-American-British classification, frequency of myeloid antigen expression and karyotypic abnormalities in 210 pediatric and adult cases
40. Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia
41. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases
42. Relapse of acute myelogenous leukemia as a cerebellar myeloblastoma showing megakaryoblastic differentiation
43. Hematological features and treatment outcome in acute myeloid leukemia with t(8;21)
44. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens: Comparison with flow cytometry
45. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders
46. Definition of biphenotypic leukemia
47. The acute erythroleukemias
48. Multifaceted approach to the diagnosis and classification of the acute leukemia
49. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia: A single center study
50. Recent advances in the study of the hereditary and environmental basis of childhood leukemia
51. Smoking and risk of leukemia
52. Electron microscopic analysis of myeloperoxidase of leukemic cells in CD7+ stem cell leukemia/lymphoma
53. Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): Homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21)
54. A classification based on T cell selection-related phenotype identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies
55. Frequent deletion of p16ONK 4a/MTS1 and p15INK 4b/MTS 2 in pediatric acute lymphoblastic leukemia
56. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukemia as compared to myeloid antigen negative acute lymphoblastic acute lymphocytic leukemia
57. Topoisomerase II inhibitor-related acute myeloid leukemia
58. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung
59. FISH analysis of an AML-5a with segmental rearrangements involving 11q23-MLL region
60. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia in elderly patients
61. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Molecular cytogenetic diagnosis in hematological malignancies
62. Childhood leukemia presenting with back pain and vertebral compression fractures
63. Molecular diagnostics
64. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia -M3
65. Lineage identification of acute leukemias: Relevance of immunologic and ultrastructural techniques
66. Sudan black B positive acute lymphoblastic leukemia
67. Adult T-cell leukemia
68. Prognostic factors in the myelodysplastic syndromes: Importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis
69. Recherches sut l'oeuif humain
70. Weisses blut
71. Carcinogenic action of alkylating agents
72. Tumor suppressor genes
73. Epipodophyllotoxin-related leukemia: Identification of a new subset of secondary leukemia
74. Acute myelomonocytic leukemia and multiple myeloma after sulphinpyrazone and colchicine treatment of gout
75. Leukaemia in benzene workers: A retrospective cohort study